Skip to content

Clinical trials

Phase 3 Squamous Cell Carcinoma of Head and Neck trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 3 Country / region: United States Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20033
20041
20054
20061
20071
20082
20091
20104
20111
20121
20131
20141
20151
20161
20174
20192
20204
20211
20231
20246
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated11
Recruiting10
Active, not recruiting8
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radiation Therapy Oncology Group12
Eastern Cooperative Oncology Group4
AstraZeneca3
Alliance for Clinical Trials in Oncology2
Bristol-Myers Squibb2
GlaxoSmithKline2
Introgen Therapeutics2
Merck Sharp & Dohme LLC2
Merus B.V.2
National Cancer Institute (NCI)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck68
Head and Neck Neoplasms41
Salivary Gland Neoplasms6
Carcinoma5
Carcinoma, Squamous Cell5
Esthesioneuroblastoma, Olfactory5
Pain5
Tongue Neoplasms4
Hypopharyngeal Neoplasms3
Laryngeal Diseases3

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.